CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 140,000 shares at $1.45 ($203,378)
- 8-K Event Bylaws or fiscal year change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- CT ORDER Other Confidential Order
- 8-K Event Material agreement
- 10-K/A Report 10-K/A
- 8-K Event Material agreement · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
Page 23 of 39 · 778 filings